Pacific RxTracts - April 2025

Articles: FDA Approves Miudella: First New Hormone-Free IUD in Over 40 Years First Treatment for Cerebrotendinous Xanthomatosis Approved Presepsin: A New Biomarker for Assessing Cardiovascular Disease New Insights into Severe NOWS Prediction Myasthenia Gravis: Nipocalimab, a Potential Add-on Therapy ARF/ARDS Concern with Trimethoprim-Sulfamethoxazole in Youth Hormone Replacement Therapy: Beneficial for Managing Menopausal Symptoms Long-Term? Esketamine Shows Promise in Preventing Postpartum Depression After Cesarean Delivery From One Week to One Hour: FDA Approves Label Changes for Sublocade Rapid Induction in Patients with Moderate to Severe Opioid Use Disorder Repurposing Semaglutide: A Novel Approach to Alcohol Use Disorder Treating Neuropathic Pain: Pregabalin vs. Gabapentin Trastuzumab Rezetecan in HER2-Mutant NSCLC: Promising Phase 2 Trial Results FDA Approval for Symptomatic Tenosynovial Giant Cell Tumor Protecting HIV Patients with Alternative HepB Vaccines FDA Approval of New Meningococcal Vaccination Has Greater Serogroup Coverage